Through its Merck Accelerator China program, Merck Group aims to identify promising startups and support them in their business development journey, explore collaboration opportunities and jointly explore innovative business opportunities to create value for the world. The six-month program runs 1 intake per year, with the focus on startups from seed to series A financing rounds in business fields including Healthcare, Life Science, Electronics, AI-enabled Health Solutions, Organoids, Bioelectronics, Liquid Biopsy, Clean Meat, and Neuromorphic Systems.